D6DMQ Trademark

Trademark Overview


On Wednesday, January 25, 2023, a trademark application was filed for D6DMQ with the United States Patent and Trademark Office. The USPTO has given the D6DMQ trademark a serial number of 79367483. The federal status of this trademark filing is REGISTERED as of Tuesday, November 28, 2023. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The D6DMQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of agitation in patients with Alzheimer's dementia, negative symptoms of schizophrenia, and traumatic brain injury
d6dmq

General Information


Serial Number79367483
Word MarkD6DMQ
Filing DateWednesday, January 25, 2023
Status700 - REGISTERED
Status DateTuesday, November 28, 2023
Registration Number7227113
Registration DateTuesday, November 28, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of agitation in patients with Alzheimer's dementia, negative symptoms of schizophrenia, and traumatic brain injury
Pseudo MarkD SIX D M Q

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Sunday, January 21, 2024NOTIFICATION PROCESSED BY IB
Thursday, January 4, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 4, 2024FINAL DISPOSITION PROCESSED
Thursday, December 28, 2023GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, November 28, 2023REGISTERED-PRINCIPAL REGISTER
Monday, September 18, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 12, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 23, 2023NOTICE OF PUBLICATION
Tuesday, August 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 1, 2023ASSIGNED TO EXAMINER
Tuesday, April 25, 2023APPLICATION FILING RECEIPT MAILED
Thursday, April 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 19, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 13, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB